ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,188.00
0.94%
Dow Jones
40,287.53
0.00%
Brent Oil
81.305
-1.18%
Bitcoin
67,426.09
-1.07%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Sutro Biopharma Inc (STRO)

  7. Sutro Biopharma Inc (STRO) News

STRO

Sutro Biopharma (STRO)

Sutro Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:STRO
DateTimeSourceHeadlineSymbolCompany
07/10/20244:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
07/10/20244:10PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
07/09/20248:00AMGlobeNewswire Inc.Sutro Biopharma Appoints Dr. Barbara Leyman as Chief Business Development OfficerNASDAQ:STROSutro Biopharma Inc
06/10/20244:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
06/10/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STROSutro Biopharma Inc
06/10/20244:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
06/10/20244:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
06/10/20244:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
05/17/20245:00PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:STROSutro Biopharma Inc
05/13/20244:34PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:STROSutro Biopharma Inc
05/13/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STROSutro Biopharma Inc
05/13/20244:30PMGlobeNewswire Inc.Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated MilestonesNASDAQ:STROSutro Biopharma Inc
04/30/20248:00AMGlobeNewswire Inc.Sutro Biopharma Announces Initiation of Randomized Portion (Part 2) of REFRĪ±ME-O1 TrialNASDAQ:STROSutro Biopharma Inc
04/02/20246:18AMGlobeNewswire Inc.Sutro Biopharma Announces Pricing of $75 Million Underwritten OfferingNASDAQ:STROSutro Biopharma Inc
03/25/20244:30PMGlobeNewswire Inc.Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated MilestonesNASDAQ:STROSutro Biopharma Inc
03/07/20244:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
03/07/20244:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
03/07/20244:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
03/07/20244:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
03/05/20244:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
03/05/20244:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
03/04/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
02/27/20244:33PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:STROSutro Biopharma Inc
02/13/202412:16PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:STROSutro Biopharma Inc
02/12/20246:06AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:STROSutro Biopharma Inc
02/09/20244:27PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STROSutro Biopharma Inc
02/09/20244:25PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:STROSutro Biopharma Inc
02/06/20244:05PMGlobeNewswire Inc.Sutro Biopharma to Participate in Upcoming Investor ConferencesNASDAQ:STROSutro Biopharma Inc
01/31/20244:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STROSutro Biopharma Inc
01/29/20245:14PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STROSutro Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:STRO

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
BIEL
Bioelectronics (PK)
USOTC
HIRU
Hiru (PK)
USOTC
SPZI
Spooz (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
VPLM
Voip Pal Com (QB)
COIN
BTCUSD
Bitcoin
NASDAQ
COOP
Mr Cooper
NASDAQ
LWLG
Lightwave Logic
NASDAQ
AVXL
Anavex Life Sciences
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
NSAV
Net Savings Link (PK)
NASDAQ
MAXN
Maxeon Solar Technologies
NASDAQ
AMRN
Amarin
USOTC
AXXA
Exxe (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved